New registry to track sleep aid safety in pregnancy

NCT ID NCT06498128

Recruiting now Knowledge-focused Sponsor: Idorsia Pharmaceuticals Ltd. Source: ClinicalTrials.gov ↗

First seen Jan 06, 2026 · Last updated May 16, 2026 · Updated 20 times

Summary

This study follows about 785 pregnant women with insomnia to compare outcomes for those who took the sleep medication QUVIVIQ during pregnancy versus those who did not. Researchers will look for birth defects and pregnancy complications. The goal is to gather safety information, not to test a new treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INSOMNIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Azienda Ospedaliera Universitaria Policlinico Tor Vergata
NOT_YET_RECRUITING

Rome, Italy
Charité - Universitätsmedizin Berlin
NOT_YET_RECRUITING

Berlin, Germany
Hospital Txagorritxu
NOT_YET_RECRUITING

Vitoria-Gasteiz, Spain
Hôpital Gui de Chauliac
NOT_YET_RECRUITING

Montpellier, France
IQVIA US Office
RECRUITING

Durham, North Carolina, 27703, United States
Jodha Tishon
NOT_YET_RECRUITING

Toronto, Ontario, Canada
University College London Hospitals
NOT_YET_RECRUITING

London, United Kingdom

Conditions

Explore the condition pages connected to this study.

INSOMNIA